A Randomized, Double-Blind, Multi-Center Phase III Study Comparing Everolimus (RAD001) plus Best Supportive Care vs. Placebo plus Best Supportive Care in Patients with Advanced gastric Cancer after Progression on Prior Systemic Chemotherapy.
|Effective start/end date
|6/23/09 → 12/31/12
- NOVARTIS PHARMACEUTICALS CORPORATION
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.